ZIOPHARM Oncology (ZIOP)

Add to Watchlists Create an Alert
2.00 +0.29  +16.96%   NASDAQ May 23, 4:58PM BATS Real time Currency in USD

ZIOPHARM Oncology Return on Equity:

-132.5% for March 31, 2013
View Full Chart

ZIOPHARM Oncology Return on Equity Chart

    ZIOPHARM Oncology Historical Return on Equity Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -132.5%
    Dec. 31, 2012 -136.4%
    Sept. 30, 2012 -102.0%
    June 30, 2012 -75.18%
    March 31, 2012 -58.69%
    Dec. 31, 2011 -90.50%
    Sept. 30, 2011 -96.59%
    June 30, 2011 -125.7%
    March 31, 2011 -122.3%
    Dec. 31, 2010 -97.83%
    Sept. 30, 2010 -70.74%
    June 30, 2010 -52.73%
    March 31, 2010 -224.9%
    Dec. 31, 2009 -86.56%
    Sept. 30, 2009 -242.8%
    June 30, 2009 -201.0%
       
    March 31, 2009 -166.3%
    Dec. 31, 2008 -145.7%
    Sept. 30, 2008 -120.7%
    June 30, 2008 -99.72%
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro

    About Return on Equity (ROE)

    Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

    ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

    Investors generally are interested in company's that have high, increasing returns on equity.
    Learn More

    Get data for

    ZIOP Return on Equity Benchmarks

    Companies
    Threshold Pharmaceuticals
    United Therapeutics Corporation 27.77%
    Celsion Corporation -154.3%

    ZIOP Return on Equity Rankings

    Overall 44th percentile
    4451 of 8006
    Sector 34th percentile
    447 of 686 in Healthcare
    Industry 45th percentile
    135 of 248 in Biotechnology

    ZIOP Return on Equity Range, Past 5 Years

    Minimum -242.8% Sep 2009
    Maximum -52.73% Jun 2010
    Average -122.4%